Ricardo Guiterrez Children's Hospital, Gallo Buenos Aires, Argentina.
Int J Infect Dis. 2010 Aug;14(8):e649-58. doi: 10.1016/j.ijid.2009.11.006. Epub 2010 Feb 23.
Diphtheria (D), tetanus (T), pertussis (P), hepatitis B (HepB), invasive Haemophilus influenzae type b (Hib) disease, and measles cause substantial global morbidity and mortality.
This unique review highlights geographic differences in disease burden across certain countries in the African, Americas, Mediterranean, South-East Asian, and Western Pacific World Health Organization (WHO) regions, and relates this to vaccination coverage and local vaccine recommendations using the authors' countries as illustrations.
Substantial differences were observed in the incidence of these diseases and in vaccination coverage between the countries studied. Disease incidence often reflected inadequate surveillance, but also variable or poor vaccination coverage. Vaccination coverage against HepB was particularly low in the African and South-East Asian WHO regions; vaccination coverage against invasive Hib disease was low in these regions and in the Eastern Mediterranean and Western Pacific WHO regions. Vaccination schedules within some countries in these regions do not include, or have only recently included, vaccinations against HepB and Hib disease. The use of DTwP-HepB-Hib (diphtheria, tetanus, whole-cell pertussis, HepB, Hib) combination vaccines has now been adopted by some countries to help increase vaccination coverage.
Vaccination coverage and vaccination schedules vary markedly between the countries studied, often according to the resources available. DTwP-HepB-Hib combination vaccines represent a cost-effective option, with the potential to substantially reduce the burden associated with these diseases by increasing coverage and compliance.
白喉(D)、破伤风(T)、百日咳(P)、乙型肝炎(HepB)、侵袭性流感嗜血杆菌 b 型(Hib)病和麻疹会导致严重的全球发病率和死亡率。
本综述突出了非洲、美洲、地中海、东南亚和西太平洋世界卫生组织(WHO)区域内某些国家在疾病负担方面的地域差异,并利用作者所在国家的情况说明了这与疫苗接种覆盖率和当地疫苗建议之间的关系。
在所研究的国家中,这些疾病的发病率和疫苗接种覆盖率存在显著差异。疾病发病率往往反映了监测不足,但也反映了疫苗接种覆盖率的差异或不足。非洲和东南亚 WHO 区域内 HepB 疫苗接种覆盖率特别低;这些区域以及东地中海和西太平洋 WHO 区域内侵袭性 Hib 疾病的疫苗接种覆盖率也较低。这些区域内的一些国家的免疫接种计划不包括或最近才包括 HepB 和 Hib 疾病的疫苗接种。一些国家现在已经采用了 DTwP-HepB-Hib(白喉、破伤风、全细胞百日咳、HepB、Hib)联合疫苗,以帮助提高疫苗接种覆盖率。
在所研究的国家中,疫苗接种覆盖率和免疫接种计划差异很大,这往往取决于可用资源。DTwP-HepB-Hib 联合疫苗是一种具有成本效益的选择,通过提高覆盖率和合规性,有可能大大减轻这些疾病的负担。